Previously, Herbrich et al. developed a novel bioinformatics approach that analyzed widely available AML gene expression datasets and found CD200 as substantially over-expressed in AML stem cells (LSCs) when compared with paired blast cells, in addition to their normal hematopoietic stem cell counterparts [26]. The gene discussed is CD200; the disease is acute myeloid leukemia.